Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chureen T Carter

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advances in Therapy|August 6, 2011
Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costsChureen T Carter, Heidi C Waters, Daniel B Smith
Patient Preference and Adherence|June 23, 2012
Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's diseaseChureen T Carter, Heidi C Waters, Daniel B Smith
Journal of Medical Economics|December 16, 2011
Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patientsChureen T Carter, Arun K Changolkar, R Scott McKenzie
The American Journal of Managed Care|July 16, 2011
Impact of persistence with infliximab on hospitalizations in ulcerative colitisChureen T Carter, Henry Leher, Paula Smith, et al.
Managed Care Interface|February 22, 2007
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspectivePeggy S McKinnon, Chureen T Carter, Prafulla G Girase, et al.
Clinical Therapeutics|November 17, 2012
Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritisSusan C Bolge, Chureen T Carter, Cynthia S Mueller, et al.
Schizophrenia Research|March 21, 2006
Effect of initial ziprasidone dose on length of therapy in schizophreniaAmie T Joyce, David J Harrison, Antony D Loebel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Burden of illness among commercially insured patients with Alzheimer's diseaseAmie T Joyce, Yang Zhao, Lee Bowman, et al.
Patient Preference and Adherence|July 1, 2015
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasisMingliang Zhang, Susan K Brenneman, Chureen T Carter, et al.
Contemporary Clinical Trials Communications|January 19, 2019
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trialKatie Baca-Motes, Alison M Edwards, Jill Waalen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advances in Therapy|August 6, 2011
Impact of infliximab adherence on Crohn's disease-related healthcare utilization and inpatient costsChureen T Carter, Heidi C Waters, Daniel B Smith
Patient Preference and Adherence|June 23, 2012
Effect of a continuous measure of adherence with infliximab maintenance treatment on inpatient outcomes in Crohn's diseaseChureen T Carter, Heidi C Waters, Daniel B Smith
Journal of Medical Economics|December 16, 2011
Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patientsChureen T Carter, Arun K Changolkar, R Scott McKenzie
The American Journal of Managed Care|July 16, 2011
Impact of persistence with infliximab on hospitalizations in ulcerative colitisChureen T Carter, Henry Leher, Paula Smith, et al.
Managed Care Interface|February 22, 2007
The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspectivePeggy S McKinnon, Chureen T Carter, Prafulla G Girase, et al.
Clinical Therapeutics|November 17, 2012
Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritisSusan C Bolge, Chureen T Carter, Cynthia S Mueller, et al.
Schizophrenia Research|March 21, 2006
Effect of initial ziprasidone dose on length of therapy in schizophreniaAmie T Joyce, David J Harrison, Antony D Loebel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Burden of illness among commercially insured patients with Alzheimer's diseaseAmie T Joyce, Yang Zhao, Lee Bowman, et al.
Patient Preference and Adherence|July 1, 2015
Patient-reported treatment satisfaction and choice of dosing frequency with biologic treatment for moderate to severe plaque psoriasisMingliang Zhang, Susan K Brenneman, Chureen T Carter, et al.
Contemporary Clinical Trials Communications|January 19, 2019
Digital recruitment and enrollment in a remote nationwide trial of screening for undiagnosed atrial fibrillation: Lessons from the randomized, controlled mSToPS trialKatie Baca-Motes, Alison M Edwards, Jill Waalen, et al.
Pageof 2